Takara Bio

Inactive

4974.T (JPX)

Takara Bio Inc. and its subsidiaries offer reagents, equipment, and contract services for genetic and cellular research worldwide, including PCR instruments, cellular analysis devices, and COVID-19 diagnostics. It supports regenerative medicine, gene analysis, and biologics development, and markets RetroNectin as well as gene therapy programs such as NY-ESO-1 siTCR and CereAAV. Based in Kusatsu, Japan, it is a Takara Holdings subsidiary.